SCHEMBL30936814

SCHEMBL30936814

COc1ccc(Nc2nc(Nc3ccc(N4CCC(N5CCN(C(=O)OC(C)(C)C)CC5)CC4)cc3OC)ncc2Cl)c(N(C)S(C)(=O)=O)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 10/20 0.74
▸ MET P08581 2/20 0.69
▸ ALK Q9UM73 11/20 0.65
▸ INSR P06213 6/20 0.59
▸ IGF1R P08069 6/20 0.59
▸ BMPR1B O00238 1/20 0.55
▸ PLK4 O00444 1/20 0.55
▸ STK25 O00506 1/20 0.55
▸ RIOK3 O14730 1/20 0.55
▸ CHEK1 O14757 1/20 0.55
▸ CASK O14936 1/20 0.55
▸ AURKA O14965 1/20 0.55
▸ GAK O14976 1/20 0.55
▸ DCLK1 O15075 1/20 0.55
▸ MUSK O15146 1/20 0.55
▸ EPHB6 O15197 1/20 0.55
▸ PDPK1 O15530 1/20 0.55
▸ MAP3K13 O43283 1/20 0.55
▸ DAPK3 O43293 1/20 0.55
▸ MAP3K7 O43318 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30497499 0.93 EGFR (0.81) EGFRMETALKINSRIGF1R
SCHEMBL26496845 0.93 EGFR (0.81) EGFRMETALKINSRIGF1R
SCHEMBL30936861 0.91 EGFR (0.62) EGFRMETALKINSRIGF1R
SCHEMBL25370102 0.91 EGFR (0.81) EGFRMETALKINSRIGF1R
SCHEMBL25874807 0.87 EGFR (0.72) EGFRMETALKINSRIGF1R
SCHEMBL30936844 0.87 EGFR (0.73) EGFRMETALKINSRIGF1R
SCHEMBL26495301 0.87 ALK (0.74) EGFRMETALKZAP70
SCHEMBL30497488 0.87 ALK (0.74) EGFRMETALKZAP70
SCHEMBL25874095 0.86 EGFR (0.72) EGFRMETALKINSRIGF1R
SCHEMBL21847000 0.85 EGFR (1.00) EGFRALKINSRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024072178-A1 COMPOUND FOR TARGETED PROTEIN DEGRADATION, AND USE THEREOF (주)사이러스테라퓨틱스 2024-04-04 — — WO disclosed
Send feedback